Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

      ( print page 51829)    
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of the President's Cancer Panel.

The meeting will be closed to the public in accordance with the provisions set forth in section 552b(c)(9)(B), Title 5 U.S.C., as amended, because the premature disclosure of information and the discussions would be likely to significantly frustrate implementation of recommendations.

*Name of Committee:*                         President's Cancer Panel                    

*Date:*                         September 2, 2005                    

*Time:*                         1 p.m. to 4 p.m.                    

*Agenda:*                         The Panel will discuss and plan the next series of meetings in 2005-2006.                    

*Place:*                         National Cancer Institute, National Institutes of Health, 6116 Executive Boulevard, Suite 212, Bethesda, MD 20892 (Teleconference)                    

*Contact Person:*                         Abby Sandler, Ph.D., Executive Secretary, National Cancer Institute, National Institutes of Health, 6116 Executive Boulevard, Suite 212, Bethesda, MD, 20892, 301/451-9399.                    

This meeting is being published less than 15 days prior to the meeting due to scheduling conflicts.

Any interested person may file written comments with the committee by forwarding the comments to the Contact Person listed on this Notice. The comments should include the name, address, telephone number and, when applicable, the business or professional affiliation of the interested person.

                        Information is also available on the Institute's/Center's home page:                         *deainfo.nci.nih.gov/advisory/pcp/pcp.htm,*                         where an agenda and any additional information for the meeting will be posted when available.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)

Dated: August 22, 2005.

Anthony M. Coelho, Jr.,

Acting Director, Office of Federal Advisory Committee Policy.

[FR Doc. 05-17256  Filed 8-30-05; 8:45 am]

BILLING CODE 4140-01-M